BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 26234674)

  • 1. Overexpression of miR-214-3p in esophageal squamous cancer cells enhances sensitivity to cisplatin by targeting survivin directly and indirectly through CUG-BP1.
    Phatak P; Byrnes KA; Mansour D; Liu L; Cao S; Li R; Rao JN; Turner DJ; Wang JY; Donahue JM
    Oncogene; 2016 Apr; 35(16):2087-97. PubMed ID: 26234674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The RNA-binding protein CUG-BP1 increases survivin expression in oesophageal cancer cells through enhanced mRNA stability.
    Chang ET; Donahue JM; Xiao L; Cui Y; Rao JN; Turner DJ; Twaddell WS; Wang JY; Battafarano RJ
    Biochem J; 2012 Aug; 446(1):113-23. PubMed ID: 22646166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of miR-199a-5p decreases esophageal cancer cell proliferation through repression of mitogen-activated protein kinase kinase kinase-11 (MAP3K11).
    Byrnes KA; Phatak P; Mansour D; Xiao L; Zou T; Rao JN; Turner DJ; Wang JY; Donahue JM
    Oncotarget; 2016 Feb; 7(8):8756-70. PubMed ID: 26717044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-483-3p plays an oncogenic role in esophageal squamous cell carcinoma by targeting tumor suppressor EI24.
    Ma J; Hong L; Xu G; Hao J; Wang R; Guo H; Liu J; Zhang Y; Nie Y; Fan D
    Cell Biol Int; 2016 Apr; 40(4):448-55. PubMed ID: 26801660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy-induced modification of microRNA expression in esophageal cancer.
    Hummel R; Wang T; Watson DI; Michael MZ; Van der Hoek M; Haier J; Hussey DJ
    Oncol Rep; 2011 Oct; 26(4):1011-7. PubMed ID: 21743970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-542-3p suppresses cellular proliferation of bladder cancer cells through post-transcriptionally regulating survivin.
    Zhang J; Wang S; Han F; Li J; Yu L; Zhou P; Chen Z; Xue S; Dai C; Li Q
    Gene; 2016 Apr; 579(2):146-52. PubMed ID: 26723509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia induces chemoresistance of esophageal cancer cells to cisplatin through regulating the lncRNA-EMS/miR-758-3p/WTAP axis.
    Zhu ZJ; Pang Y; Jin G; Zhang HY; Wang WH; Liu JW; Tuo GX; Wu P; Yang Y; Wang ZQ; Wang K
    Aging (Albany NY); 2021 Jun; 13(13):17155-17176. PubMed ID: 34081626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BAG3-mediated miRNA let-7g and let-7i inhibit proliferation and enhance apoptosis of human esophageal carcinoma cells by targeting the drug transporter ABCC10.
    Wu K; Yang Y; Zhao J; Zhao S
    Cancer Lett; 2016 Feb; 371(1):125-33. PubMed ID: 26655271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complex Epigenetic Regulation of Chemotherapy Resistance and Biohlogy in Esophageal Squamous Cell Carcinoma via MicroRNAs.
    Lindner K; Eichelmann AK; Matuszcak C; Hussey DJ; Haier J; Hummel R
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29414899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-542-3p exerts tumor suppressive functions in neuroblastoma by downregulating Survivin.
    Althoff K; Lindner S; Odersky A; Mestdagh P; Beckers A; Karczewski S; Molenaar JJ; Bohrer A; Knauer S; Speleman F; Epple M; Kozlova D; Yoon S; Baek K; Vandesompele J; Eggert A; Schramm A; Schulte JH
    Int J Cancer; 2015 Mar; 136(6):1308-20. PubMed ID: 25046253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD.
    Chen Y; Ke G; Han D; Liang S; Yang G; Wu X
    Exp Cell Res; 2014 Jan; 320(1):12-20. PubMed ID: 24183997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Esophageal squamous cell carcinoma cell proliferation induced by exposure to low concentration of cigarette smoke extract is mediated via targeting miR-101-3p/COX-2 pathway.
    Gong J; Chu Y; Xu M; Huo J; Lv L
    Oncol Rep; 2016 Jan; 35(1):463-71. PubMed ID: 26530100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonizing miR-455-3p inhibits chemoresistance and aggressiveness in esophageal squamous cell carcinoma.
    Liu A; Zhu J; Wu G; Cao L; Tan Z; Zhang S; Jiang L; Wu J; Li M; Song L; Li J
    Mol Cancer; 2017 Jun; 16(1):106. PubMed ID: 28633632
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Akdemir B; Nakajima Y; Inazawa J; Inoue J
    Mol Cancer Res; 2017 Nov; 15(11):1570-1578. PubMed ID: 28760781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.
    Hu Y; Xu K; Yagüe E
    Breast Cancer Res Treat; 2015 Jun; 151(2):269-80. PubMed ID: 25900794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-141-3p regulates cellular proliferation, migration, and invasion in esophageal cancer by targeting tuberous sclerosis complex 1.
    Phatak P; Noe M; Asrani K; Chesnick IE; Greenwald BD; Donahue JM
    Mol Carcinog; 2021 Feb; 60(2):125-137. PubMed ID: 33382472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting miR-21-3p inhibits proliferation and invasion of ovarian cancer cells.
    Báez-Vega PM; Echevarría Vargas IM; Valiyeva F; Encarnación-Rosado J; Roman A; Flores J; Marcos-Martínez MJ; Vivas-Mejía PE
    Oncotarget; 2016 Jun; 7(24):36321-36337. PubMed ID: 27166999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNAs: Key regulators of chemotherapy response and metastatic potential via complex control of target pathways in esophageal adenocarcinoma.
    Matuszcak C; Lindner K; Eichelmann AK; Hussey DJ; Haier J; Hummel R
    Surg Oncol; 2018 Sep; 27(3):392-401. PubMed ID: 30217293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α-solanine enhances the chemosensitivity of esophageal cancer cells by inducing microRNA‑138 expression.
    Wu J; Wang L; Du X; Sun Q; Wang Y; Li M; Zang W; Liu K; Zhao G
    Oncol Rep; 2018 Mar; 39(3):1163-1172. PubMed ID: 29328459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased expression of miR-542-3p exerts growth inhibitory functions in esophageal cancer.
    Chen BB; Chen XB; Bie LY; Mu Y; Wang HL; Lv HF; Li N; Ma YJ; Ding ZD; Luo SX
    J Cancer Res Ther; 2015 Aug; 11 Suppl 1():C24-8. PubMed ID: 26323919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.